Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Oramed Pharmaceuticals Inc banner

Oramed Pharmaceuticals Inc
NASDAQ:ORMP

Watchlist Manager
Oramed Pharmaceuticals Inc Logo
Oramed Pharmaceuticals Inc
NASDAQ:ORMP
Watchlist
Price: 4.7 USD -0.84% Market Closed
Market Cap: $192.4m
Write Note Create Alert Ask AI

Wall St Price Targets

ORMP Price Forecast
Based on 3 analysts

+52% Upside
from $4.7 today

ORMP Analyst Rating
Based on 1 analyst

Strong buy
0 0%
Buy
0 0%
Hold
1 100%
Sell
0 0%
Strong sell
0 0%
Oramed Pharmaceuticals Inc Competitors:
Price Targets

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
236% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
236% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

The compound annual growth rate for Pre-Tax Income over the next 1 year is 236%.

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
200% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
200% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

The compound annual growth rate for Net Income over the next 1 year is 200%.

What are analyst estimates?

Continue ORMP Research

Summary
ORMP intrinsic value, competitors valuation, and company profile.
DCF Valuation
ORMP stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ORMP stock valuation using valuation multiples.
Wall St Estimates
ORMP price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ORMP stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Oramed Pharmaceuticals Inc listings:
F • EUR
OJU1
 TASE • ILS
ORMP
 SWB • EUR
OJU1
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is ORMP's stock price target?
Price Target
7.14 USD

According to Wall Street analysts, the average 1-year price target for ORMP is 7.14 USD with a low forecast of 7.07 USD and a high forecast of 7.35 USD.

What is the Pre-Tax Income forecast for Oramed Pharmaceuticals Inc?
Projected CAGR
236%

The compound annual growth rate for Pre-Tax Income over the next 1 year is 236%.

What is the Net Income forecast for Oramed Pharmaceuticals Inc?
Projected CAGR
200%

The compound annual growth rate for Net Income over the next 1 year is 200%.

Back to Top
ALPHA SPREAD
Follow us
Join 358,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.